StockData
CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31

Altamira Therapeutics Ltd.

Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Altamira Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Altamira Therapeutics filed with the SEC